Tilray Brands announced the acquisition of HelloMD Corporation, a digital patient engagement startup, to expand its direct-to-patient capabilities.
Financial terms of the transaction were not disclosed.
The acquisition will strengthen Tilray’s global medical cannabis platform by expanding direct-to-patient capabilities, enhancing physician and patient education, and deepening engagement across the care journey, while establishing an integrated Canadian framework that connects quality cultivation, clinical expertise, practitioner support, product access, and fulfillment.
HelloMD Corporation is a leading digital healthcare and patient engagement platform focused on medical cannabis education, physician consultations, and patient support services. Through its technology-driven approach, HelloMD helps patients navigate medical cannabis treatment with confidence and access trusted healthcare resources.
More than 5000 digital health companies have been acquired to date, according to our recent M&A Database. More recently, PsychPlus, a leader in psychiatric and therapeutic care, announced the acquisition of Koa Health, a digital mental health startup, presently operating throughout Europe, Asia, and Australia.